SHANGHAI JUNSHI BIOSCIENCES CO., LTD. · 君实生物
Last · HKSEHK$16.18-0.22 (-1.34%)live · yahoo · 2h ago
Vol 1.80M ≈ 29.06M
MA10MA20MA50
Market capHK$16.6B260.3M sh
P/E · TTM-40.7fwd 81.1 · eps -0.45 · loss
Beta—vs S&P 500
Div yield0.00%annual · TTM
52w range
HK$15.25HK$30.80
Volume1.8Msession
Issuer
Legal nameSHANGHAI JUNSHI BIOSCIENCES CO., LTD. · 君实生物
HQHong Kong (HK)
ListingHK 1877
ISINCNE100003FF7
SectorHealthcare
IndustryPharmaceuticals
CurrencyCNY
Entity registrycninfo:GFBJ0833330
Org IDGFBJ0833330
Websitewww.junshipharma.com
Employees2,903
AddressShanghai Junshi Biosciences Co., Ltd. 13th Floor, Building 2 201203, Shanghai
| Revenue | ¥1.7B |
|---|---|
| Operating income | ¥70.9M |
| Net income | ¥25.5M |
| Operating margin | 4.2% |
| Net margin | 1.5% |
| Return on equity | 0.0% |
| Period | 2026 |
Loading chart…
Upcoming earnings
WED.28OCT
9:10 AM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
Press & signals
- GlobeNewswire
Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates
Documents
FormReporting forFiledFlags
Showing 5 of 87 filings